The plan to scrap the UK’s ONS Covid survey
Experts suggest ‘world’s best surveillance system’ could protect against future pandemics

Plans to scrap the Office for National Statistics’ (ONS) “gold standard” weekly Covid-19 survey have been greeted with dismay by experts and commentators.
The survey, which measures both infection rates and antibodies across the country, is due to lapse this spring and will be either “scaled back” or “phased out altogether” if Rishi Sunak does not sign off on funding for another year, the i reported.
But with experts warning that another pandemic is possible in the coming decades, ditching the scheme is being described as a short-sighted move that could prove counterproductive.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
‘Global standard setter’
The ONS weekly survey has been tracking the same households since June 2020 and is therefore not subject to fluctuations in numbers of people self-testing for Covid-19. It employs more than 2,000 people, who visit the same households regularly.
The survey, which has been praised by the World Health Organization, regularly tests around 100,000 people to provide an “unbiased estimate” of the prevalence of Covid in the UK, said The Times’ science editor Tom Whipple.
Unlike community testing, the survey is “not self-selecting, so it picks up people who would not get tested or who do not know they are infected”, he added.
With mass testing also expected to be scaled back, the daily case count published online will become less and less representative of the true number of infections. This, experts say, would make the ONS data increasingly valuable.
Wales’s economy minister, Vaughan Gething, told Times Radio that the ONS infection survey is “even more important now because of the changes made to testing policy in all parts of the UK”.
And former Downing Street adviser Dominic Cummings tweeted that “abandoning” the “global standard setter” would be “so stupid”, claiming that the plan to scrap the scheme is a “Tory policy to save money”.
Professor Danny Altmann, an expert in immunology at Imperial College London, said it would be “incredibly counterproductive to axe” the survey, while Rupert Beale, clinical science group leader at the Francis Crick Institute, said it is a “flat-out terrible decision”.
Epidemiologist Adam Kucharski told the i it was “crucial to have good information on what’s happening”, and Christina Pagel of University College London said “we need ONS weekly population surveillance on Covid to combine with hospital and death data”.
In The Observer, columnist Will Hutton described the planned scrapping of the “highly regarded survey” as part of a “reckless libertarian dash” for the “Covid exit”.
With life increasingly returning to normal, the ONS study “allows the UK to pick up the emergence of high-risk variants”, he warned, describing the surveillance tracker as “public goods for which we readily pay”.
Future-proofing
The widely praised system could have future applications, said The Times’ Whipple, and marks the “greatest effort to track a disease in the history of humanity”.
With future funding, it could be that the ONS runs a “smaller – in both frequency and numbers – version of the survey” with a view to tracking other infections such as influenza.
Ian Diamond, the UK’s national statistician, told the paper that maintaining the infrastructure of the national survey could serve as an insurance policy, suggesting that if another novel virus emerged “it would have the ability to expand very, very quickly”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Ione Skye's 6 favorite books about love and loss
Feature The actress recommends works by James Baldwin, Nora Ephron, and more
By The Week US
-
Book review: 'Miracles and Wonder: The Historical Mystery of Jesus' and 'When the Going Was Good: An Editor's Adventures During the Last Golden Age of Magazines'
Feature The college dropout who ruled the magazine era and the mysteries surrounding Jesus Christ
By The Week US
-
Not invincible: Tech burned by tariff war
Feature Tariffs on Asian countries are shaking up Silicon Valley, driving up prices and deepening global tensions
By The Week US
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
By The Week US
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK